|
Sign In to gain access to subscriptions and/or personal tools.
|
MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS)
Frederik Barkhof
MS-MRI centre and Department of Radiology, Vrije Universiteit Hospital Amsterdam, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands
Magnetic resonance (MR) imaging is very sensitive in showing disseminated MS lesions. Subclinical MR progression occurs frequently, explaining why MR is now used to monitor treatment, even without measurable consequences, of new MR lesions to the patient at this moment. In the light of this clinico-radiological paradox, the significance of MR in MS is discussed, particularly in relation with the expanded disability status scale (EDSS). Gadolinium-enhancing lesions correlate with the occurrence of relapses, CSF myelin breakdown products and, in patients with relapsingremitting disease, with higher EDSS. However, the predictive value of the frequency of enhancement for changes in EDSS is only weak. For conventional T2-weighted MR imaging, the cross-sectional correlation with EDSS varies between 0.15 and 0.60, and is limited mainly by the inherent lack of tissues specificity of T2-weighted images. Both T1 black holes and magnetisation transfer (MT) parameters show a better correlation with EDSS; it should be noted that lesions in which those abnormalities are found go through an initial phase of enhancement as well. For T1 black holes, a correlation up to 0.81 has been reported for SP patients. Post-mortem studies show that black holes and low MT ratios are in vivo markers of axonal loss. Preliminary data indicate that progressive atrophy also correlates with progression on the EDSS scale. More should be learned about the fate of new MR lesion with regards to development of axonal loss, which at present is difficult to predict in the enhancing stage. The existence of escape mechanisms, including remyelination, make a simple correlation with EDSS extremely unlikely, and perhaps not even desirable. Nevertheless, while the clinical effect of a given new lesion may be difficult to ascertain, the absence of (new) MR lesions is prognostically favourable, as will be the degree to which new lesions are prevented by treatment.
Key Words: magnetic resonance imaging • multiple sclerosis • expanded disability status scale
Multiple Sclerosis, Vol. 5, No. 4,
283-286 (1999)
DOI: 10.1177/135245859900500415
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. D. Budde, M. Xie, A. H. Cross, and S.-K. Song
Axial Diffusivity Is the Primary Correlate of Axonal Injury in the Experimental Autoimmune Encephalomyelitis Spinal Cord: A Quantitative Pixelwise Analysis
J. Neurosci.,
March 4, 2009;
29(9):
2805 - 2813.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Strasser-Fuchs, C. Enzinger, S. Ropele, M. Wallner, and F. Fazekas
Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox?
Multiple Sclerosis,
March 1, 2008;
14(2):
205 - 211.
[Abstract]
[PDF]
|
|
|
|
|
|
|
O. Khan
Can clinical outcomes be used to detect neuroprotection in multiple sclerosis?
Neurology,
May 29, 2007;
68(22_suppl_3):
S64 - S71.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M C. Otaduy, D Callegaro, L A Bacheschi, and C C Leite
Correlation of magnetization transfer and diffusion magnetic resonance imaging in multiple sclerosis
Multiple Sclerosis,
November 1, 2006;
12(6):
754 - 759.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Bakshi, G. J. Hutton, J. R. Miller, and E.-W. Radue
The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis
Neurology,
December 14, 2004;
63(11_suppl_5):
S3 - S11.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. Sharma, M. P. Sanfilipo, R. H. B. Benedict, B. Weinstock-Guttman, F. E. Munschauer III, and R. Bakshi
Whole-Brain Atrophy in Multiple Sclerosis Measured by Automated versus Semiautomated MR Imaging Segmentation
AJNR Am. J. Neuroradiol.,
June 1, 2004;
25(6):
985 - 996.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Liu and L. Blumhardt
Randomized, double-blind, placebo-controlled study of subcutaneous interferon beta-Ia in relapsing-remitting multiple sclerosis: a categorical disability trend analysis
Multiple Sclerosis,
September 1, 2002;
8(1_suppl):
10 - 14.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Bonneville, D. M. Moriarty, B. S.Y. Li, J. S. Babb, R. I. Grossman, and O. Gonen
Whole-Brain N-Acetylaspartate Concentration: Correlation with T2-Weighted Lesion Volume and Expanded Disability Status Scale Score in Cases of Relapsing-Remitting Multiple Sclerosis
AJNR Am. J. Neuroradiol.,
March 1, 2002;
23(3):
371 - 375.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Liu and L D Blumhardt
Randomized, double-blind, placebo-controlled study of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis: a categorical disability trend analysis
Multiple Sclerosis,
February 1, 2002;
8(1):
10 - 14.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. A. Bermel, R. Bakshi, C. Tjoa, S. R. Puli, and L. Jacobs
Bicaudate Ratio as a Magnetic Resonance Imaging Marker of Brain Atrophy in Multiple Sclerosis
Arch Neurol,
February 1, 2002;
59(2):
275 - 280.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Bakshi, R. H. B. Benedict, R. A. Bermel, S. D. Caruthers, S. R. Puli, C. W. Tjoa, A. J. Fabiano, and L. Jacobs
T2 Hypointensity in the Deep Gray Matter of Patients With Multiple Sclerosis: A Quantitative Magnetic Resonance Imaging Study
Arch Neurol,
January 1, 2002;
59(1):
62 - 68.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. G Lynch, D. C Kroencke, and D. R Denney
The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope
Multiple Sclerosis,
December 1, 2001;
7(6):
411 - 416.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V. Janardhan and R. Bakshi
Quality of Life and Its Relationship to Brain Lesions and Atrophy on Magnetic Resonance Images in 60 Patients With Multiple Sclerosis
Arch Neurol,
October 1, 2000;
57(10):
1485 - 1491.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
